Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2008
11/05/2008CN101300350A Promoter for introducing gene into lymphocyte or blood cell and application thereof
11/05/2008CN101300346A Novel biological substance nesfatin and its related substances and uses thereof
11/05/2008CN101300274A Immunomodulatory compositions and uses therefor
11/05/2008CN101300273A TRAIL recipient 2 Polypeptides and antibodies
11/05/2008CN101300272A Compositions and methods for treating proliferative disorders
11/05/2008CN101300029A Antineoplastic combinations with mtor inhibitor,herceptin, and/or hki-272
11/05/2008CN101300028A Live attenuated rotavirus vaccine for oral administration
11/05/2008CN101300027A Secretory IgA and IgG antibodies-inducing agent
11/05/2008CN101300026A Multifunctional biomaterials as scaffolds for electronic, optical, magnetic, semiconducting, and biotechnological applications
11/05/2008CN101300024A Tnf-alpha blocker treatment for enterocolitis associated with immunostimulatory therapeutic antibody therapy
11/05/2008CN101300023A Use of vaccines for the treatment/ prevention of the transmission of influenza pathogens between species
11/05/2008CN101298615A Novel anti-plasmodium falciparum epitope and vaccine containing the same
11/05/2008CN101298481A Inhibitors of complement activation
11/05/2008CN101298479A Antibodies for inhibiting blood coagulation and methods of use thereof
11/05/2008CN101298473A Conserved neisserial antigens
11/05/2008CN101298471A Epitope capable of exciting human body anti-mycobacterium tuberculosis protective immunity reaction and use thereof
11/05/2008CN101297968A Preparation of pig serum immunoglobulin microsphere novel dosage form
11/05/2008CN101297967A Novel use of staphylococcus enterotoxin A gene
11/05/2008CN101297966A Tumor vaccine for intestinal cancer containing rich chaperone-antigenic peptide complexes and preparation thereof
11/05/2008CN100430482C Novel expression vectors and uses thereof
11/05/2008CN100430478C CASB618 polynucleotides and polypeptides and their use
11/05/2008CN100430420C Human CDR-grafted antibodies and antibody fragments thereof
11/05/2008CN100430419C Anti-CD40 monoclonal antibody
11/05/2008CN100430418C Method of preparing monoclonal antibody, monoclonal antibody, pharmaceutical composition and diagnostic reagent
11/04/2008US7446191 Expression vector comprising nucleotide sequences coding t-cell receptor for use in generation of monoclonal antibody for treatement of cell proliferative disorders
11/04/2008US7446189 Use as vaccine adjuvants; useful in the treatment of autoimmune diseases and immunosuppression
11/04/2008US7446185 Vector comprising nucleotide sequences coding oncogenic protein for use in identication of modulators for treatment and prevention of cell proliferative and metabolic disorders
11/04/2008US7446182 Recombinant antibodies for the detection and neutralization of anthrax toxin
11/04/2008US7446180 Conformationally abnormal forms of tau proteins and specific antibodies thereto
11/04/2008US7446179 CD19-specific chimeric T cell receptor
11/04/2008US7446177 Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infection
11/04/2008US7446175 Antibodies to human IL-1β
11/04/2008US7446173 amino acid sequence coupled to a non-naturally-occurring polyoxyalkylene glycol at N-terminal end of glycosylated interferon-beta-1a through a coupling group such as aldehyde, maleimide, a vinylsulfone,or haloacetate groups; enhanced activity; Multiple sclerosis; cancer; therapeutical; water solubility
11/04/2008US7446168 Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) for use as a tool in treatment and prevention of urogenital and cell proliferative disorders; fertility aide
11/04/2008US7446095 Peptides modulating caspase activation
11/04/2008US7446089 such as lactoferrin, conalbumin; combinations with antibiotics, microbiocides for e.g. disinfecting, preserving food, treating infections; also chelating agents such as ,19,30-trioxa-1,4,10,13,16,22,27,33-octaazabicyclo(11,11,11)pentatriacontane hexahydrobromide
11/04/2008US7445930 Method for the production and purification of adenoviral vectors
11/04/2008US7445928 Bacterial artificial chromosome construct encoding recombinant coronavirus
11/04/2008US7445924 Modified Vaccinia Ankara virus variant and cultivation method
11/04/2008US7445905 Contacting cells with receptor and determining formation of complexes; modulating gene expression in acinar cells of pancreatitis associated protein
11/04/2008US7445802 Conjugates of alliinase with a protein carrier that targets the alliinase to specific cells are used in combination with alliin to produce allicin at a desired target site to kill cancer cells or pathogens.
11/04/2008US7445798 Transgenic cells comprising nucleotide sequences coding fetal liver kinase-1 receptors; for use self-renewal of totipotent hematopoietic stem cell and to stimulate the development of all cells of the hematopoietic system both in vitro and in vivo
11/04/2008US7445794 Administering 2-deoxy-D-glucose and etomoxir and anti-Fas antibody for cancer therapy
11/04/2008US7445787 Veterinary medicine; brain disorders; immunizing with vaccine comprising West Nile virus or plasmid DNA, an adjuvant such as a metabolizable oil carrier
11/04/2008US7445786 Diagnosing and protecting against tursiops truncatus papillomavirus
11/04/2008US7445785 Vaccine; use in the protection of poultry against infectious bronchitis; can be administered via the in ovo route without having a negative impact on the hatchability of the vaccinated embryonated egg
11/04/2008US7445784 Apoptosis of rectum and prostate cancer
11/04/2008US7445783 topical application of a composition of urea and a chemotherapeutic agent such as sclerosing agents, vasodilators and botulinum toxin; spider veins, erectile dysfunction and facial wrinkles
11/04/2008US7445782 Antibodies for preventing and treating attaching and effacing Escherichia coli (AEEC) associated diseases
11/04/2008US7445781 Inhibits B-cell activation by binding to protein receptor on helper T-cell membrane; treatment of allergy or autoimmune disease
11/04/2008US7445780 Antagonistic anti-CD40 antibodies
11/04/2008US7445779 Methods of modulating IFNy production
11/04/2008CA2330186C Divalent antibody fragments
11/04/2008CA2197432C Liquid immunoglobulin formulations
11/04/2008CA2182890C Targeted cytolysis of hiv-infected cells by chimeric cd4 receptor-bearing cells
11/04/2008CA2136870C Anti-aids immunomodulation complex
10/2008
10/30/2008WO2008131406A2 NEGATIVE IMMUNOMODULATION OF IMMUNE RESPONSES BY ERp5
10/30/2008WO2008131376A2 Methods and compositions for treating and monitoring treatment of il-13-associated disorders
10/30/2008WO2008131339A1 Microbial host-vector complementation system
10/30/2008WO2008131315A2 Identification and method for using the pre-ligand assembly domain of the il-17 receptor
10/30/2008WO2008131298A2 Prevention and treatment of cerebral amyloid angiopathy
10/30/2008WO2008131242A1 Single chain fc, methods of making and methods of treatment
10/30/2008WO2008131170A1 Aerosol dispersions of particles with active pharmaceutical ingredients
10/30/2008WO2008131006A2 Method for inhibiting scavenger receptor-a and increasing immune response to antigens
10/30/2008WO2008130917A1 Composition comprising various salmonella subspecies and method for controlling intestinal pathogenic organisms
10/30/2008WO2008130719A1 Therapeutic beta-glucan combinations
10/30/2008WO2008130551A2 Antibiotic resistance free listeria strains and methods for constructing and using same
10/30/2008WO2008129559A2 Antigenic polysaccharides and process for their preparation
10/30/2008WO2008129426A2 Medicaments and methods to treat autoimmune disease and cancer
10/30/2008WO2008129265A1 Diagnostics and therapeutics for diabetic nephropathy involving ccl18
10/30/2008WO2008129263A1 Antibodies against il-25
10/30/2008WO2008129124A1 Novel fully human anti-vap-1 monoclonal antibodies
10/30/2008WO2008129103A1 Use of african swine pest haemoglutinin as an adjuvant
10/30/2008WO2008129058A1 Duck embryonic derived stem cell lines for the production of viral vaccines
10/30/2008WO2008129020A1 Vaccination regimen for b-cell vaccines
10/30/2008WO2008128939A1 Oil-in-water emulsion influenza vaccine
10/30/2008WO2008128456A1 The functional epitope of osteopontin, the anti-osteoponin monoclonal antibody and use thereof
10/30/2008WO2008128455A1 Osteopontin functional epitopes, monoclonal antibodies against the epitopes and uses thereof
10/30/2008WO2008110379A3 Monoclonal antibodies for treatment of cancer
10/30/2008WO2008109533A3 Human antibodies that bind multiple irta family proteins, and uses thereof
10/30/2008WO2008108830A3 Immunogenic and therapeutic compositions for streptococcus pyogenes
10/30/2008WO2008106980A3 Recombinant antibodies for treatment of respiratory syncytial virus infections
10/30/2008WO2008103471A3 Methods to activate or block the hla-e/qa-1 restricted cd8+ t cell regulatory pathway to treat immunological disease
10/30/2008WO2008097817A3 Multivariable antigens complexed with targeting humanized monoclonal antibody
10/30/2008WO2008094188A3 Methods and compositions using listeria for enhancing immunogenicity by prime boost
10/30/2008WO2008092854A3 Papillomavirus e2 polypeptide used for vaccination
10/30/2008WO2008091398A3 Jc virus vaccine
10/30/2008WO2008088895A3 Synthetic mini/micro-dystrophin genes to restore nnos to the sarcolemma
10/30/2008WO2008088594A3 Isolation of antibodies that cross-react and neutralize rankl orginating from multiple species
10/30/2008WO2008088583A3 Cytotoxic t-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
10/30/2008WO2008084237A3 Stabilization of aqueous compositions of proteins with displacement buffers
10/30/2008WO2008079326A3 Methods for using and identifying modulators of delta-like 4
10/30/2008WO2008079172A3 Compositions comprising hmw-maa and fragments thereof, and methods of use thereof
10/30/2008WO2008078177A3 Method for producing catalytic antibodies (variants), antigens for immunization and nucleotide sequence
10/30/2008WO2008073464A3 Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
10/30/2008WO2008073312A3 Urokinase-type plasminogen activator receptor epitope, monoclonal antibodies derived therefrom and methods of use thereof
10/30/2008WO2008070593A3 Variant target binding agents and uses thereof
10/30/2008WO2008031056A3 Humanized anti-cd19 antibodies and their use in treatment of oncology, transplantation and autoimmune disease
10/30/2008WO2008008526A3 Treating obesity and gastro-intestinal disorders using botulinum toxin
10/30/2008WO2007148229A3 Immunogenic multivalent adhesin particles
1 ... 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 ... 1823